COVID-19
Pfizer has published promising follow-up data from a late-stage trial of its coronavirus vaccine in adolescents, showing a 100% efficacy rate in those between 12 and 15 years of age. The data demonstrates the vaccine's safety and effectiveness in this age group, which has seen a rise in
COVID-19
Following the approval by the Centers for Disease Control and Prevention, select Publix pharmacies have begun providing Moderna and Pfizer COVID-19 booster doses to eligible adults aged 18 and older, no sooner than six months after completion of their initial series. In addition to booster shots, Publix pharmacies continue to
COVID-19
Individuals across the nation can now receive a Pfizer, Moderna, or Johnson & Johnson COVID-19 vaccine booster in Walgreens stores nationwide, following the Food and Drug Administration's (FDA) expanded Emergency Use Authorization and the Centers for Disease Control and Prevention's (CDC) new guidance. This move aims
COVID-19
Pfizer Inc, a leading pharmaceutical company, has announced an agreement with the US government to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candidate, PAXLOVID. This move is part of the company's efforts to combat the ongoing pandemic, with PAXLOVID being the first oral antiviral
COVID-19
Scientists at Massachusetts Institute of Technology have made a significant breakthrough in the field of cancer treatment, using the same mRNA technology that was successful in developing COVID-19 vaccines. By learning how to "awaken" T cells and reinvigorate the body's natural cancer-fighting abilities, researchers hope to
COVID-19
Blood cancer patients who have been double-vaccinated against COVID-19 are still left vulnerable to the virus, with more than half unable to mount an antibody response to SARS-CoV-2, researchers have found. The study, which was published in a letter to Cancer Cell, examined the immune protection offered by delayed Pfizer
COVID-19
The United States has entered a new phase in its COVID-19 vaccination campaign, with shots now available to millions of elementary-age children. This development comes after more than 18 months of illness, hospitalizations, and deaths, as well as disrupted education. With the federal government promising enough vaccine to protect the
COVID-19
Experts are weighing the benefits and risks of vaccinating all children in this age group, considering the potential impact of COVID-19 on kids and the effectiveness of the vaccine. The Center for Disease Control and Prevention (CDC) must sign off before widespread vaccinations can begin. Doctors who have cared for
COVID-19
The global osteoarthritis therapeutics market reached a value of nearly US$8 Billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.4% during 2021-2026. The market is driven by factors such as the growing geriatric population, sedentary lifestyles, and unhealthy dietary patterns,
COVID-19
Major pharmacies in the US have begun offering COVID-19 booster shots, with the latest guidance from the US health officials allowing for the extra dose for Moderna and Johnson & Johnson vaccines. The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have signed off
COVID-19
Walmart and Sam's Club pharmacies are now ready to administer booster shots for Moderna and Johnson & Johnson (J&J) COVID-19 vaccines, following the Centers for Disease Control and Prevention's (CDC) authorization. This development comes after Pfizer's COVID-19 vaccine became eligible as a
COVID-19
Effective October 14, 2021, the government of the Cayman Islands has implemented new laws concerning immigration and Customs and Border Control. The new regulations require all eligible individuals immigrating to the Cayman Islands to be fully vaccinated and provide proof of COVID-19 vaccination to the Department of Immigration (WORC) and
